Harvard Apparatus Regenerative Technology, Inc. SEC filings HRGN
Harvard Apparatus Regenerative Technology, Inc. has 625 filings in SEC EDGAR's recent list, going back to Dec 11, 2012. Its latest annual report, Form 10-K, was filed on Mar 19, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 14, 2026 (material agreement, unregistered share sale). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEF 14A | Proxy statement | Apr 23, 2026 | Jun 18, 2026 |
| DEF 14A | Proxy statement | Apr 29, 2025 | Jun 20, 2025 |
| PRE 14A | Preliminary proxy statement | Apr 17, 2025 | Jun 20, 2025 |
| DEF 14A | Proxy statement | Apr 29, 2024 | Apr 29, 2024 |
| DEFA14A | Additional proxy material | Jun 7, 2023 | — |
| DEF 14A | Proxy statement | Jun 5, 2023 | Jun 5, 2023 |
| DEF 14A | Proxy statement | Jul 5, 2022 | Jul 28, 2022 |
| PRE 14A | Preliminary proxy statement | Jun 23, 2022 | Jul 28, 2022 |
| DEFA14A | Additional proxy material | May 2, 2022 | — |
| DEF 14A | Proxy statement | May 2, 2022 | Jun 22, 2022 |
| DEFA14A | Additional proxy material | Apr 30, 2021 | — |
| DEF 14A | Proxy statement | Apr 30, 2021 | Jun 24, 2021 |
| DEFA14A | Additional proxy material | Apr 28, 2020 | — |
| DEF 14A | Proxy statement | Apr 28, 2020 | Jun 18, 2020 |
| DEFA14A | Additional proxy material | Apr 11, 2019 | — |
| DEF 14A | Proxy statement | Apr 11, 2019 | May 24, 2019 |
| PRE 14A | Preliminary proxy statement | Apr 1, 2019 | May 24, 2019 |
| DEFA14A | Additional proxy material | Apr 13, 2018 | — |
| DEF 14A | Proxy statement | Apr 13, 2018 | May 23, 2018 |
| DEF 14A | Proxy statement | Mar 24, 2017 | Apr 26, 2017 |
| PRE 14A | Preliminary proxy statement | Mar 14, 2017 | Mar 14, 2017 |
| DEF 14A | Proxy statement | Apr 22, 2016 | May 26, 2016 |
| PRE 14A | Preliminary proxy statement | Apr 5, 2016 | Apr 5, 2016 |
| DEFA14A | Additional proxy material | Apr 17, 2015 | — |
| DEFA14A | Additional proxy material | Apr 10, 2015 | — |
| DEF 14A | Proxy statement | Apr 9, 2015 | May 21, 2015 |
| DEFA14A | Additional proxy material | Apr 10, 2014 | — |
| DEF 14A | Proxy statement | Apr 10, 2014 | May 21, 2014 |
Showing 28 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- HRGN (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Holliston, MA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1563665
- Former names
- Biostage, Inc. (until Jul 10, 2023)
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.